<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the past, the standard management for patients with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was esophagectomy, in part on the basis of the assumption that the patient was likely to harbor an undetected <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>With better awareness of the safety of surveillance protocols, improved prospective surveillance, and experience with cohorts of patients in whom incident early lesions unassociated with invasive <z:mp ids='MP_0002038'>carcinomas</z:mp> are detected, endoscopic techniques for treatment of Barrett-associated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> have become excellent alternatives to esophagectomy for appropriately selected patients </plain></SENT>
<SENT sid="2" pm="."><plain>Emerging endoscopic techniques offer an opportunity for better evaluation of patients with Barrett's-associated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
</text></document>